Amantadine Hydrochloride Cap · 415 days since initial FDA posting
Brand: AMANTADINE HYDROCHLORIDE
FDA lists Amantadine Hydrochloride Cap as To Be Discontinued (Upsher-Smith Laboratories, LLC).
No availability text on this FDA row.
Amantadine Hydrochloride Capsule: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Amantadine Hydrochloride Capsule
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Dosage Form
- Capsule
- Presentation
- Amantadine Hydrochloride, Capsule, 100 mg (NDC 0832-1015-50)
- Package NDC
- 0832-1015-50
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jul 23, 2025
- Last Updated
- Jul 23, 2025
- Therapeutic Category
- Antiviral, Neurology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug product
Nearby, Other Amantadine Shortage Records
Amantadine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet
Amantadine Hydrochloride Capsule
Upsher-Smith Laboratories, LLC
Capsule
Amantadine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet
Amantadine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet
FDA reason on file: Discontinuation of the manufacture of the drug product. General shortage guidance lives on the tracker hub.